Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

November 10, 2021

Hologic’s profits dropped 34%, as demand for COVID tests fell

Photo | Grant Welker Hologic's Marlborough headquarters

Marlborough medical device manufacturer Hologic, Inc., earned profits of $329 million in the fourth quarter, a 34% decrease from the fourth quarter 2020's profits of $494 million, according to the company's earnings report.

Hologic’s total revenue of $1.32 billion for the quarter was a 2.3% decrease compared to the prior year fourth quarter of $1.35 billion, according to the report released Nov. 1. The company attributes this drop to lower sales of COVID-19 tests, per the press release.

While the sales of COVID-19 assays declined, Hologic experienced positive growth in its breast health and GYN surgical divisions.  

On the day the earnings report came out, Hologic's stock price on the NASDAQ dropped 2.4% from $72.68 per share at the start of trading on Nov. 1 to $70.91 by the following day's open. Year-to-date, the company's stock has lost about 1% of its value, trading at $72.45 on Wednesday morning.
 

Sign up for Enews

WBJ Web Partners

Related Content

0 Comments

Register for free to read more articles.

Register Now

Already have an online account? Login

To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy

Allow Cookies